These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10218674)

  • 1. Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
    Asch PH; Basset P; Roos M; Grosshans E; Bellocq JP; Cribier B
    Am J Dermatopathol; 1999 Apr; 21(2):146-50. PubMed ID: 10218674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
    Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
    Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of stromelysin 3 in basal cell carcinomas.
    Cribier B; Noacco G; Peltre B; Grosshans E
    Eur J Dermatol; 2001; 11(6):530-3. PubMed ID: 11701402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
    Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
    Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar organizer region enumeration in keratoacanthomas and squamous cell carcinomas of the skin.
    Kanitakis J; Hoyo E; Hermier C; Chouvet B; Thivolet J
    Cancer; 1992 Jun; 69(12):2937-41. PubMed ID: 1591687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.
    Kuivanen TT; Jeskanen L; Kyllönen L; Impola U; Saarialho-Kere UK
    Mod Pathol; 2006 Sep; 19(9):1203-12. PubMed ID: 16699496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGP 9.5 expression in cutaneous keratoacanthomas and squamous cell carcinomas.
    Mastoraki A; Ioannidis E; Patsouris E; Safioleas M; Aroni K
    Arch Dermatol Res; 2009 Oct; 301(9):653-8. PubMed ID: 19488775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
    Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in tumor microvessel density between squamous cell carcinomas and basal cell carcinomas may relate to their different biologic behavior.
    Weninger W; Rendl M; Pammer J; Grin W; Petzelbauer P; Tschachler E
    J Cutan Pathol; 1997 Jul; 24(6):364-9. PubMed ID: 9243364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the nucleoside diphosphate kinase in human skin cancers: an immunohistochemical study.
    Ro YS; Jeong SJ
    J Korean Med Sci; 1995 Apr; 10(2):97-102. PubMed ID: 7576301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
    Cain CT; Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders.
    Thewes M; Worret WI; Engst R; Ring J
    Clin Exp Dermatol; 1999 Mar; 24(2):122-6. PubMed ID: 10233668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
    Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
    J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers.
    Kerkelä E; Ala-aho R; Lohi J; Grénman R; M-Kähäri V; Saarialho-Kere U
    Br J Cancer; 2001 Mar; 84(5):659-69. PubMed ID: 11237387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans.
    Cribier B; Noacco G; Peltre B; Grosshans E
    J Am Acad Dermatol; 2002 Mar; 46(3):408-13. PubMed ID: 11862177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen (PCNA) expression in pseudoepitheliomatous hyperplasia, keratoacanthoma and squamous cell carcinoma of the skin.
    Li J; Lee YS
    Ann Acad Med Singap; 1996 Jul; 25(4):526-30. PubMed ID: 8893923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases.
    Cribier B; Asch P; Grosshans E
    Dermatology; 1999; 199(3):208-12. PubMed ID: 10592399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.
    Binder M; Steiner A; Mossbacher U; Hunegnaw M; Pehamberger H; Wolff K
    Am J Dermatopathol; 1998 Oct; 20(5):453-8. PubMed ID: 9790104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
    Porte H; Triboulet JP; Kotelevets L; Carrat F; Prévot S; Nordlinger B; DiGioia Y; Wurtz A; Comoglio P; Gespach C; Chastre E
    Clin Cancer Res; 1998 Jun; 4(6):1375-82. PubMed ID: 9626453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
    Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
    Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.